1. Home
  2. MCHX vs EDAP Comparison

MCHX vs EDAP Comparison

Compare MCHX & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

N/A

Current Price

$1.70

Market Cap

71.6M

ML Signal

N/A

Logo EDAP TMS S.A.

EDAP

EDAP TMS S.A.

HOLD

Current Price

$3.80

Market Cap

75.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCHX
EDAP
Founded
2003
1979
Country
United States
France
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.6M
75.5M
IPO Year
2004
1997

Fundamental Metrics

Financial Performance
Metric
MCHX
EDAP
Price
$1.70
$3.80
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$8.50
AVG Volume (30 Days)
22.2K
77.3K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$46,494,000.00
$74,853,925.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.70
$2.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.61
52 Week Low
$1.26
$1.21
52 Week High
$2.31
$3.92

Technical Indicators

Market Signals
Indicator
MCHX
EDAP
Relative Strength Index (RSI) 55.25 71.31
Support Level $1.59 $3.15
Resistance Level $1.69 $3.45
Average True Range (ATR) 0.07 0.32
MACD 0.00 0.06
Stochastic Oscillator 68.79 82.39

Price Performance

Historical Comparison
MCHX
EDAP

About MCHX Marchex Inc. Class B

Marchex Inc harnesses the power of AI and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration. Marchex enables executive, sales, and marketing teams to optimize customer journey experiences across communications channels, enabling enterprise strategies, empowering businesses to increase revenue through informed decision-making and strategic execution.

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Share on Social Networks: